Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Section Navigation
			
			CDC Home


Facebook
        Twitter
        LinkedIn
        Syndicate





National Occupational Research Agenda (NORA)										Related Pages
										1999
DHHS (NIOSH) Publication Number 99-108
cover page for publication 99-108
In April 1996, The National Institute for Occupational Safety and Health (NIOSH) and its partners unveiled the National Occupational Research Agenda (NORATM), a framework to guide occupational safety and health research into the next decade. NORA is a tool not only for NIOSH but for the entire occupational safety and health community. Approximately 500 organizations and individuals outside NIOSH provided input into the development of the Agenda. Prior to NORA, there had been no national research agenda in the field of occupational safety and health (and no research agenda in any field) which had captured such broad input and consensus. This unique process resulted in remarkable agreement about the top 21 research priorities (see below).
NORA Priority Research Areas
**Disease and Injury**
Allergic and Irritant Dermatitis
Asthma and Chronic Obstructive Pulmonary Disease
Fertility and Pregnancy Abnormalities
Hearing Loss
Infectious Diseases
Low Back Disorders
Musculoskeletal Disorders of the Upper Extremities
Traumatic Injuries
**Work Environment and Workforce**
Emerging Technologies
Indoor Environment
Mixed Exposures
Organization of Work
Special Populations at Risk
**Research Tools and Approaches**
Cancer Research Methods
Control Technology and Personal Protective Equipment
Exposure Assessment Methods
Health Services Research
Intervention Effectiveness Research
Risk Assessment Methods
Social and Economic Consequences of Workplace Illness and Injury
Surveillance Research Methods
NORA arose out of a need to address the changes in the U.S. workplace as well as the increasingly diversified workforce. The distribution of jobs in the U.S. economy continues to shift from manufacturing to services. Longer hours, compressed workweeks, shift work, reduced job security, and part-time and temporary work are realities of the modern workplace. The U.S. workforce will grow to an estimated 147 million by the year 2005, with minorities representing 28% of the workforce and women approximately 48%.
NORA also provides a means to target research in areas with the highest likelihood of reducing the still significant toll of workplace illness and injury. Each day, an average of 9,000 workers sustain disabling injuries on the job, 16 workers die from a workplace injury and 137 workers die from work-related diseases.
These injuries and deaths continue to inflict a tremendous toll in both human and economic costs. A NIOSH-funded study published in 1997 showed that in 1992, indirect and direct costs (including administrative costs) of occupational injuries and illnesses totaled $171 billion ($145 billion for injuries and $26 billion for diseases). These costs compare to $33 billion for AIDS, $67 billion for Alzheimer’s Disease, $164 billion for circulatory diseases, and $171 billion for cancer.
These numbers alone point to the need for continued occupational safety and health research. However, research efforts in both the public and private sector face increasing fiscal constraints. Through NORA and its collaborative structure the nation is better positioned to address the toll of workplace injury, illness and death.
Implementation
The development of NORA was only the first step in the effort between NIOSH and its many partners to guide and promote occupational safety and health research. Since NORA was announced, there has been a common commitment to implement the Agenda primarily by increasing activities and resources in the 21 priority areas.
Twenty Partnership Teams (the two musculoskeletal priority research areas are being addressed by one team) were formed to assist in the implementation of the agenda. Each team consists of a team leader, NIOSH researchers, and external partners. The 20 Partnership Teams have brought together 120 NIOSH researchers and 150 external members including representatives from academia, labor, industry, health and safety organizations, the insurance industry and other government organizations.
A NORA Liaison Committee and a Federal Liaison Committee also have important roles in the implementation of NORA. Both committees provide outreach and help guide the progress and direction of NORA implementation.
A Broad-Based Partnership
NORA has been successful on many levels. In March 1998, NIOSH, in partnership with three Institutes of the National Institutes of Health (the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Environmental Health Sciences, and the National Heart, Lung, and Blood Institute) announced an $8 million investment in investigator-initiated occupational safety and health research (the largest single infusion of funding ever). The investment will support grants for studies in selected NORA high priority areas and represents a three-year commitment of $24 million.
Early in the NORA process, NIOSH made a commitment to redirect some of its resources to the 21 NORA priority areas. Out of an overall operating budget in FY 96 of $165.3 million, the NIOSH baseline investment in the NORA priority areas was $15.4 million (approximately 9% of the budget). Of this, $8.7 million was devoted to intramural research (NIOSH-conducted) and cooperative agreements (NIOSH-funded extramural research that NIOSH initiates and participates in) and $6.7 million for research grants (extramural investigator-initiated projects). A redirection of resources in FY 97 nearly doubled this investment to $28.1million.
A new $5 million special Congressional appropriation to NIOSH in FY 98 for NORA, coupled with additional reinvestment of baseline monies into NORA priority areas, resulted in an estimated $46.9 million of research (about 25% of the budget) in NORA priority areas for FY 98. Such an increase is tangible evidence of NIOSH’s commitment to NORA. This shift is particularly notable given existing Congressional mandates and obligations that limit how much of the budget can be redirected.
The Federal Liaison Committee was instrumental in conducting the first-ever Federal survey of occupational safety and health research. The survey identified a total of only $204 million for all occupational safety and health research from **all** Federal sources. The FY 96 baseline for NORA from non-NIOSH Federal sources was about $15 million. Federal partners have agreed to perform the survey biannually. The next survey will assess FY 98 expenditures.
The Partnership Teams have also had much success in collaborating with key stakeholders, defining research needs and leveraging resources for research. The teams have published white papers, held conferences and workshops, developed surveys, established graduate-level training programs, participated in continuing medical education workshops and developed documents.
Further successes for NORA include NORA’s selection as a semifinalists for the prestigious Innovations in American Government Award sponsored by the Ford Foundation and administered by Harvard University’s John F. Kennedy School of Government. The number of organizations using NORA as a model for creating research agendas or other types of partnership and planning is also noteworthy. Examples include the Italian National Institute for Occupational Safety and Health, the Department of Defense and the Chemical Industry Institute of Toxicology.
National Occupational Research Agenda (NORA)pdf icon [PDF – 43 KB]
							
					
						Page last reviewed:  June 6, 2014					Content source: 	National Institute for Occupational Safety and Health homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue